VEGFA and retinal detachment: Intravitreal anti-VEGF monotherapy, systemic carbonic anhydrase inhibitor, intraocular methotrexate, and intravenous immunoglobulin did not improve BCVA or serous retinal detachment.[2] In the present study, anti-VEGF monotherapy was effective for at least 4 months in patient 3.